Sign Up to like & get
recommendations!
0
Published in 2020 at "Chinese clinical oncology"
DOI: 10.21037/cco-20-209
Abstract: Retroperitoneal sarcomas (RPSs) are rare diseases, and the 5-year overall survival rate remains low. Management of RPSs is challenging, and the quality of treatment strategy is a crucial prognostic factor. Treatment decisions and the treatment…
read more here.
Keywords:
narrative review;
retroperitoneal;
treatment;
radiotherapy ... See more keywords